BRIEF-Cg Oncology Provides Updated Timeline For Pivot-006 Phase 3 Topline Data In Intermediate-Risk Nmibc

Reuters
Jan 09
BRIEF-Cg Oncology Provides Updated Timeline For Pivot-006 Phase 3 Topline Data In Intermediate-Risk Nmibc

Jan 9 (Reuters) - CG Oncology Inc CGON.O:

  • CG ONCOLOGY PROVIDES UPDATED TIMELINE FOR PIVOT-006 PHASE 3 TOPLINE DATA IN INTERMEDIATE-RISK NMIBC

  • CG ONCOLOGY INC - EXPECTS PHASE 3 PIVOT-006 DATA IN 1H 2026

Source text: ID:nGNX9Y2PmR

Further company coverage: CGON.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10